Lowenstein Sandler has announced that Steven S. Rogers has joined the firm as partner in the Transactions & Advisory Group.

Rogers joins the firm with decades of experience in-house as General Counsel of public and private companies in diverse and highly regulated industries. He most recently served as Chief Legal Officer at Aceto Corporation (Aceto), a global company focused on the development, manufacturing, and distribution of pharmaceuticals, nutraceuticals, and specialty chemicals, with $650+ million in annual revenue and offices and operations in 10 countries. There he oversaw all legal and regulatory matters and provided legal counsel to the company’s senior management and board on matters of corporate governance, internal investigations, securities issues, corporate communications, and regulatory and antitrust concerns, in addition to legal aspects of business strategies, operations, and human resources.

“Steve’s deep in-house experience will be a true asset to our clients, as will his talent for strategic thinking and risk management,” said Steven E. Siesser, partner and Co-chair of the firm’s Transactions & Advisory Group and Chair of its Private Equity group.

As part of its long-term representation of Aceto, Lowenstein Sandler worked with the company on the recent completion of its two major asset sales for nearly $600 million, as well as its Chapter 11 filing.

“Lowenstein helped create the best possible outcome for Aceto,” said Rogers. “Shareholders and directors complimented the firm for the exemplary professionalism and speed with which the matter was handled. Having had a front-row seat to how the entire team developed and executed the perfect strategy for my former company, it is a thrill for me to now join their partnership and continue our productive working relationship.”

Prior to his work in the pharmaceutical and chemical industries, Rogers spent over 10 years as General Counsel to an SEC-registered investment adviser, where he was responsible for all legal, compliance, and regulatory matters. He acted as lead strategic advisor to numerous portfolio companies, advising on legal matters impacting core investment themes, including consumer goods, pharmaceuticals, health care, chemicals, mergers and acquisitions, financial services/credit facilities, and transportation.

Beginning his legal career in private practice at an Am Law 200 firm, Rogers focused on both corporate and litigation matters, including internal corporate investigations and counseling on litigation prevention and cost-efficient legal budgeting.